Skip to main navigation Skip to search Skip to main content

Diagnostic Accuracy of Amyloid versus 18F-Fluorodeoxyglucose Positron Emission Tomography in Autopsy-Confirmed Dementia

  • Orit H. Lesman-Segev
  • , Renaud La Joie
  • , Leonardo Iaccarino
  • , Iryna Lobach
  • , Howard J. Rosen
  • , Sang Won Seo
  • , Mustafa Janabi
  • , Suzanne L. Baker
  • , Lauren Edwards
  • , Julie Pham
  • , John Olichney
  • , Adam Boxer
  • , Eric Huang
  • , Marilu Gorno-Tempini
  • , Charles DeCarli
  • , Mackenzie Hepker
  • , Ji Hye L. Hwang
  • , Bruce L. Miller
  • , Salvatore Spina
  • , Lea T. Grinberg
  • William W. Seeley, William J. Jagust, Gil D. Rabinovici
  • University of California at San Francisco
  • Sheba Medical Center at Tel Hashomer
  • Sungkyunkwan University
  • Lawrence Berkeley National Laboratory
  • University of California at Davis
  • University of California at Berkeley

Research output: Contribution to journal › Article › peer-review

Abstract

Objective: The purpose of this study was to compare the diagnostic accuracy of antemortem 11C-Pittsburgh compound B (PIB) and 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) versus autopsy diagnosis in a heterogenous sample of patients. Methods: One hundred one participants underwent PIB and FDG PET during life and neuropathological assessment. PET scans were visually interpreted by 3 raters blinded to clinical information. PIB PET was rated as positive or negative for cortical retention, whereas FDG scans were read as showing an Alzheimer disease (AD) or non-AD pattern. Neuropathological diagnoses were assigned using research criteria. Majority visual reads were compared to intermediate–high AD neuropathological change (ADNC). Results: One hundred one participants were included (mean age = 67.2 years, 41 females, Mini-Mental State Examination = 21.9, PET-to-autopsy interval = 4.4 years). At autopsy, 32 patients showed primary AD, 56 showed non-AD neuropathology (primarily frontotemporal lobar degeneration [FTLD]), and 13 showed mixed AD/FTLD pathology. PIB showed higher sensitivity than FDG for detecting intermediate–high ADNC (96%, 95% confidence interval [CI] = 89–100% vs 80%, 95% CI = 68–92%, p = 0.02), but equivalent specificity (86%, 95% CI = 76–95% vs 84%, 95% CI = 74–93%, p = 0.80). In patients with congruent PIB and FDG reads (77/101), combined sensitivity was 97% (95% CI = 92–100%) and specificity was 98% (95% CI = 93–100%). Nine of 24 patients with incongruent reads were found to have co-occurrence of AD and non-AD pathologies. Interpretation: In our sample enriched for younger onset cognitive impairment, PIB-PET had higher sensitivity than FDG-PET for intermediate–high ADNC, with similar specificity. When both modalities are congruent, sensitivity and specificity approach 100%, whereas mixed pathology should be considered when PIB and FDG are incongruent. ANN NEUROL 2021;89:389–401.

Original languageEnglish
Pages (from-to)389-401
Number of pages13
JournalAnnals of Neurology
Volume89
Issue number2
DOIs
StatePublished - Feb 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Diagnostic Accuracy of Amyloid versus 18F-Fluorodeoxyglucose Positron Emission Tomography in Autopsy-Confirmed Dementia'. Together they form a unique fingerprint.

Cite this